Division of Child and Adolescent Health
Link-Gelles, R., Levy, M. E., Gaglani, M., Irving, S. A., Stockwell, M., Dascomb, K., DeSilva, M. B., Reese, S. E., Liao, I. C., Ong, T. C., Grannis, S. J., McEvoy, C., Patel, P., Klein, N. P., Hartmann, E., Stenehjem, E., Natarajan, K., Naleway, A. L., Murthy, K., Rao, S., … Tenforde, M. W. (2022). Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. MMWR. Morbidity and mortality weekly report, 71(29), 931–939. https://doi.org/10.15585/mmwr.mm7129e1
Firestein, M. R., Shuffrey, L. C., & Dumitriu, D. (2022). COVID-19 Pandemic Effects on Neurodevelopment?-Reply. JAMA pediatrics, 176(7), 726–727. https://doi.org/10.1001/jamapediatrics.2022.1014
Natarajan, K., Prasad, N., Dascomb, K., Irving, S. A., Yang, D. H., Gaglani, M., Klein, N. P., DeSilva, M. B., Ong, T. C., Grannis, S. J., Stenehjem, E., Link-Gelles, R., Rowley, E. A., Naleway, A. L., Han, J., Raiyani, C., Benitez, G. V., Rao, S., Lewis, N., Fadel, W. F., … Dixon, B. E. (2022). Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. MMWR. Morbidity and mortality weekly report, 71(13), 495–502. https://doi.org/10.15585/mmwr.mm7113e2